Literature DB >> 32744078

Is the lack of evidence in older adults with cancer compromising safety?

Darryl Outlaw1, Grant R Williams1,2.   

Abstract

The number of older adults with cancer is increasing, and this group is forecasted to represent a larger portion of the field of oncology over the decades to come. Many unique challenges exist in the care of older adults with cancer, from age-related changes in physiology to the increased presence of comorbidities, polypharmacy, and geriatric syndromes. Unfortunately, there remains a significant knowledge gap in the optimal management of this growing population, as the majority of cancer research and clinical trials focus on younger, healthier patients, which consequently complicates the applicability of this work in the older adult population and potentially compromises safety. In this article, we further explore the challenges facing the field of geriatric oncology and discuss strategies to close the knowledge gap facing older adults with cancer.

Entities:  

Keywords:  Geriatric oncology; aging; cancer; evidence-based medicine; frailty; polypharmacy

Mesh:

Year:  2020        PMID: 32744078      PMCID: PMC7554204          DOI: 10.1080/14740338.2020.1805429

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  12 in total

1.  Under-representation of older adults in cancer registration trials: known problem, little progress.

Authors:  Kevin S Scher; Arti Hurria
Journal:  J Clin Oncol       Date:  2012-04-30       Impact factor: 44.544

2.  Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey.

Authors:  E Paillaud; P Soubeyran; P Caillet; T Cudennec; E Brain; C Terret; F Etchepare; L Mourey; T Aparicio; F Pamoukdjian; R A Audisio; S Rostoft; A Hurria; C Bellera; S Mathoulin-Pélissier
Journal:  Eur J Cancer       Date:  2018-09-11       Impact factor: 9.162

3.  Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries.

Authors:  Supriya Gupta Mohile; Ying Xian; William Dale; Susan G Fisher; Miriam Rodin; Gary R Morrow; Alfred Neugut; William Hall
Journal:  J Natl Cancer Inst       Date:  2009-07-28       Impact factor: 13.506

4.  The Impact of Polypharmacy on Patient Outcomes in Older Adults With Cancer.

Authors:  Ginah Nightingale; Emily Skonecki; Manpreet K Boparai
Journal:  Cancer J       Date:  2017 Jul/Aug       Impact factor: 3.360

Review 5.  Geriatric Assessment: Precision Medicine for Older Adults With Cancer.

Authors:  Grant R Williams
Journal:  J Oncol Pract       Date:  2018-02       Impact factor: 3.840

6.  Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment.

Authors:  Ronald J Maggiore; William Dale; Cary P Gross; Tao Feng; William P Tew; Supriya G Mohile; Cynthia Owusu; Heidi D Klepin; Stuart M Lichtman; Ajeet Gajra; Rupal Ramani; Vani Katheria; Laura Zavala; Arti Hurria
Journal:  J Am Geriatr Soc       Date:  2014-07-15       Impact factor: 5.562

7.  Expanding the Evidence Base in Geriatric Oncology: Action Items From an FDA-ASCO Workshop.

Authors:  Laura A Levit; Harpreet Singh; Heidi D Klepin; Arti Hurria
Journal:  J Natl Cancer Inst       Date:  2018-11-01       Impact factor: 13.506

8.  Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast Cancer.

Authors:  Courtney P Williams; Kelly M Kenzik; Andres Azuero; Grant R Williams; Maria Pisu; Karina I Halilova; Stacey A Ingram; Supriya K Yagnik; Andres Forero; Smita Bhatia; Gabrielle B Rocque
Journal:  Oncologist       Date:  2018-08-17

9.  Future of cancer incidence in the United States: burdens upon an aging, changing nation.

Authors:  Benjamin D Smith; Grace L Smith; Arti Hurria; Gabriel N Hortobagyi; Thomas A Buchholz
Journal:  J Clin Oncol       Date:  2009-04-29       Impact factor: 44.544

10.  Assessment of Sarcopenia Measures, Survival, and Disability in Older Adults Before and After Diagnosis With Cancer.

Authors:  Grant R Williams; Yanjun Chen; Kelly M Kenzik; Andrew McDonald; Shlomit S Shachar; Heidi D Klepin; Stephen Kritchevsky; Smita Bhatia
Journal:  JAMA Netw Open       Date:  2020-05-01
View more
  5 in total

1.  Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US.

Authors:  Theresa Ermer; Maureen E Canavan; Richard C Maduka; Andrew X Li; Michelle C Salazar; Michael F Kaminski; Matthew D Pichert; Peter L Zhan; Vincent Mase; Harriet Kluger; Daniel J Boffa
Journal:  JAMA Netw Open       Date:  2022-06-01

2.  The association of polypharmacy with functional status impairments, frailty, and health-related quality of life in older adults with gastrointestinal malignancy - Results from the Cancer and Aging Resilience Evaluation (CARE) registry.

Authors:  Darryl Outlaw; Chen Dai; Mustafa Al-Obaidi; Christian Harmon; Smith Giri; Smita Bhatia; Grant R Williams
Journal:  J Geriatr Oncol       Date:  2022-01-05       Impact factor: 3.929

3.  Age-related Differences in Recall of Information and Handling of Chemotherapy-related Side Effects in Cancer Patients: The ReCap Study.

Authors:  Cecilia Margareta Lund; M K Mikkelsen; S Theile; H M Michelsen; M Schultz; L Sengeløv; D L Nielsen
Journal:  Oncologist       Date:  2022-03-04       Impact factor: 5.837

Review 4.  Current Challenges Faced by Cancer Clinical Trials in Addressing the Problem of Under-Representation of Older Adults: A Narrative Review.

Authors:  Ruth M Parks; Holly M Holmes; Kwok-Leung Cheung
Journal:  Oncol Ther       Date:  2021-01-22

Review 5.  Challenges of Survivorship for Older Adults Diagnosed with Cancer.

Authors:  Margaret I Fitch; Irene Nicoll; Lorelei Newton; Fay J Strohschein
Journal:  Curr Oncol Rep       Date:  2022-03-14       Impact factor: 5.945

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.